85 related articles for article (PubMed ID: 7536039)
21. Identification of GIYWHHY as a novel peptide substrate for human p60c-src protein tyrosine kinase.
Lou Q; Leftwich ME; Lam KS
Bioorg Med Chem; 1996 May; 4(5):677-82. PubMed ID: 8804533
[TBL] [Abstract][Full Text] [Related]
22. Identification of platelet membrane proteins that interact with amino-terminal peptides of pp60c-src.
Feder D; Bishop JM
J Biol Chem; 1991 Oct; 266(28):19040-6. PubMed ID: 1717459
[TBL] [Abstract][Full Text] [Related]
23. Potent pseudosubstrate-based peptide inhibitors for p60(c-src) protein tyrosine kinase.
Lou Q; Leftwich ME; McKay RT; Salmon SE; Rychetsky L; Lam KS
Cancer Res; 1997 May; 57(10):1877-81. PubMed ID: 9157979
[TBL] [Abstract][Full Text] [Related]
24. Recombinant pp60c-src from baculovirus-infected insect cells: purification and characterization.
Budde RJ; Ramdas L; Ke S
Prep Biochem; 1993 Nov; 23(4):493-515. PubMed ID: 7504254
[TBL] [Abstract][Full Text] [Related]
25. Development and characterization of potent and specific peptide inhibitors of p60c-src protein tyrosine kinase using pseudosubstrate-based inhibitor design approach.
Kamath JR; Liu R; Enstrom AM; Lou Q; Lam KS
J Pept Res; 2003 Dec; 62(6):260-8. PubMed ID: 14632929
[TBL] [Abstract][Full Text] [Related]
26. Structural determinants for potent, selective dual site inhibition of human pp60c-src by 4-anilinoquinazolines.
Tian G; Cory M; Smith AA; Knight WB
Biochemistry; 2001 Jun; 40(24):7084-91. PubMed ID: 11401553
[TBL] [Abstract][Full Text] [Related]
27. A protein kinase assay system for both acidic and basic peptides.
Lou Q; Wu J; Lam KS
Anal Biochem; 1996 Mar; 235(1):107-9. PubMed ID: 8850556
[No Abstract] [Full Text] [Related]
28. Identification and characterization of a novel synthetic peptide substrate specific for Src-family protein tyrosine kinases.
Lam KS; Wu J; Lou Q
Int J Pept Protein Res; 1995 Jun; 45(6):587-92. PubMed ID: 7558590
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
Cobb BS; Parsons JT
Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
[TBL] [Abstract][Full Text] [Related]
31. Development of solid-phase enzyme-linked immunosorbent assays for the determination of epidermal growth factor receptor and pp60c-src tyrosine protein kinase activity.
Farley K; Mett H; McGlynn E; Murray B; Lydon NB
Anal Biochem; 1992 May; 203(1):151-7. PubMed ID: 1381873
[TBL] [Abstract][Full Text] [Related]
32. pp60c-src expression in rat spermatogenesis.
Nishio H; Tokuda M; Itano T; Matsui H; Takeuchi Y; Hatase O
Biochem Biophys Res Commun; 1995 Jan; 206(2):502-10. PubMed ID: 7530000
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate.
Maa MC; Wilson LK; Moyers JS; Vines RR; Parsons JT; Parsons SJ
Oncogene; 1992 Dec; 7(12):2429-38. PubMed ID: 1281304
[TBL] [Abstract][Full Text] [Related]
34. Studies on the primary sequence requirements for PKC-alpha, -beta 1 and -gamma peptide substrates.
Marais RM; Nguyen O; Woodgett JR; Parker PJ
FEBS Lett; 1990 Dec; 277(1-2):151-5. PubMed ID: 1702730
[TBL] [Abstract][Full Text] [Related]
35. High-throughput identification of substrate specificity for protein kinase by using an improved one-bead-one-compound library approach.
Kim YG; Shin DS; Kim EM; Park HY; Lee CS; Kim JH; Lee BS; Lee YS; Kim BG
Angew Chem Int Ed Engl; 2007; 46(28):5408-11. PubMed ID: 17554743
[No Abstract] [Full Text] [Related]
36. Fully automated synthesis of (phospho)peptide arrays in microtiter plate wells provides efficient access to protein tyrosine kinase characterization.
Saxinger C; Conrads TP; Goldstein DJ; Veenstra TD
BMC Immunol; 2005 Jan; 6():1. PubMed ID: 15647109
[TBL] [Abstract][Full Text] [Related]
37. Modulation of prostaglandin G/H synthase expression in mesangial cells transfected by pp60c-src proto-oncogene.
Reiser CO; Marx M; Hoppe J; Goppelt-Struebe M
Exp Cell Res; 1996 Feb; 222(2):304-11. PubMed ID: 8598218
[TBL] [Abstract][Full Text] [Related]
38. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
Potts WM; Reynolds AB; Lansing TJ; Parsons JT
Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine phosphorylation of G protein alpha subunits by pp60c-src.
Hausdorff WP; Pitcher JA; Luttrell DK; Linder ME; Kurose H; Parsons SJ; Caron MG; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5720-4. PubMed ID: 1378615
[TBL] [Abstract][Full Text] [Related]
40. Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Translocation of pp60c-src and integrin alpha IIb beta 3 (glycoprotein IIb/IIIa) is not required for aggregation, but is dependent on formation of large aggregate structures.
Pumiglia KM; Feinstein MB
Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):253-60. PubMed ID: 7689831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
